Should we use extracorporeal photopheresis more often? Evidence from graft-versus-host disease patients monitored with Treg as a biomarker

Background: Chronic graft-versus-host disease (cGvHD) is a major complication after allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) is an immunotherapy treatment for cGvHD, although suitable response biomarkers are lacking. Materials & methods: We analyzed data...

Full description

Bibliographic Details
Published in:	Future Science OA
Main Authors:	Sérgio Machado Lopes, Susana Roncon, Ana Catarina Pinho, Filipa Bordalo, Luís Antunes, Fernando Campilho, António Campos, Altamiro Costa-Pereira
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-09-01
Subjects:	ECP extracorporeal photopheresis GvHD immunotherapy Treg
Online Access:	https://www.future-science.com/doi/10.2144/fsoa-2020-0107

Similar Items

Extracorporeal photopheresis reduces the T cell stimulatory capacity of human primary blood conventional dendritic cells type 1
by: Lukas Heger, et al.
Published: (2025-08-01)

Extracorporeal Photopheresis in Graft-Versus-Host Disease: Real-Life Experience Using a New In-Line Method
by: Giulia De Fusco, et al.
Published: (2025-01-01)

Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
by: Matthew Mankarious, et al.
Published: (2020-01-01)

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
by: Ines Bojanic, et al.
Published: (2023-02-01)

Advances in extracorporeal photopheresis
by: Zhanrui CHENG, et al.
Published: (2022-07-01)

Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects
by: Lei Wang, et al.
Published: (2018-10-01)

A survey of extracorporeal photopheresis treatment in pediatric patients in the United Kingdom
by: Aisling M. Flinn, et al.
Published: (2020-07-01)

What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
by: Oleg E. Akilov
Published: (2023-09-01)

Shaping of CD56bri Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal Photopheresis
by: Ming Ni, et al.
Published: (2019-03-01)

Recipient Tregs: Can They Be Exploited for Successful Hematopoietic Stem Cell Transplant Outcomes?
by: Sabrina N. Copsel, et al.
Published: (2022-06-01)

Exosomal-miRNas expression and growth factors released by mononuclear cells of CLAD patients in response to extracorporeal photopheresis
by: Sara Bozzini, et al.
Published: (2024-03-01)

ECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working party
by: Olaf Penack, et al.
Published: (2023-12-01)

Extracorporeal Photopheresis—An Overview
by: Ara Cho, et al.
Published: (2018-08-01)

Lessons from the discontinuation of extracorporeal photopheresis
by: Kyle R. Brownback
Published: (2017-06-01)

Regulatory T cell therapies: from patient data to biological insights
by: Kameron B. Rodrigues, et al.
Published: (2025-10-01)

Non-Invasive Diagnosis of Pediatric Intestinal Graft-Versus-Host Disease: A Case Series
by: Manuela Spadea, et al.
Published: (2022-03-01)

Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease
by: Hongnga T. Le, et al.
Published: (2020-02-01)

Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
by: Mauro Di Ianni, et al.
Published: (2024-01-01)

Established and Emerging Treatments of Skin GvHD
by: Cornelia S. Link-Rachner, et al.
Published: (2022-02-01)

Acute graft versus host disease 1976–2020: reduced incidence and predictive factors
by: Alessandra Di Francesco, et al.
Published: (2024-01-01)

Extracorporeal photopheresis in stiff person syndrome
by: Yandy Marx Castillo-Aleman, et al.
Published: (2024-12-01)

In vitro effects of different 8-methoxypsoralen treatment protocols for extracorporeal photopheresis on mononuclear cells
by: Holger Budde, et al.
Published: (2017-05-01)

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
by: B. Linder Grønvold, et al.
Published: (2024-02-01)

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
by: Andrey Kozlov, et al.
Published: (2021-08-01)

Beyond 8-methoxypsoralen as the photosensitizer for extracorporeal photopheresis
by: Yandy Marx Castillo-Aleman
Published: (2022-10-01)

Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults
by: Cécile Robinson, et al.
Published: (2017-03-01)

A genome-wide association study on hematopoietic stem cell transplantation reveals novel genomic loci associated with transplant outcomes
by: Albert Rosenberger, et al.
Published: (2024-02-01)

Editorial: Rising stars: cell and stem cell transplantation 2022
by: Raffaella Greco, et al.
Published: (2024-01-01)

Clinical use of statins in hematopoietic stem cell transplantation: Old drugs and new horizons
by: Mehdi Mohammadi, et al.
Published: (2016-04-01)

Quilty Effect after Extracorporeal Photopheresis in a Patient with Severe Refractory Cardiac Allograft Rejection
by: Özgür Ulaş Özcan, et al.
Published: (2014-12-01)

Thymoma-associated multiorgan autoimmunity treated with multimodal therapy including extracorporeal photopheresis
by: Chikoti M. Wheat, MD, et al.
Published: (2021-10-01)

Extracorporeal photopheresis reduces inflammation and joint damage in a rheumatoid arthritis murine model
by: Yuwei Lin, et al.
Published: (2024-03-01)

Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
by: Maja-Theresa Dieterlen, et al.
Published: (2021-08-01)

A European Multi-Center Analysis of Extracorporeal Photopheresis as Therapy for Chronic Lung Allograft Dysfunction
by: Alberto Benazzo, et al.
Published: (2024-01-01)

Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity
by: Brian C. Betts, et al.
Published: (2018-12-01)

Retrospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease—an analysis from transplant centers across Europe
by: Ronja Langer, et al.
Published: (2024-03-01)

Inhibition of CD38 enzyme activity on engrafted human immune cells enhances NAD+ metabolism and inhibits inflammation in an in-vivo model of xeno-GvHD
by: Ghenima Ahmil-Boiteau, et al.
Published: (2025-10-01)

Treatment of steroid-refractory graft versus host disease in children
by: Francesca Gottardi, et al.
Published: (2023-09-01)

Allele Frequencies of HLA Class-I Loci in the Normal Iranian Population
by: Andisheh Ghashghaie, et al.
Published: (2009-06-01)

Successful use of dupilumab in recalcitrant pediatric atopic dermatitis-like graft-versus-host disease: A case series
by: Lina Belmesk, MD, et al.
Published: (2024-02-01)